[ Price : $8.95]
FDA says it will begin removing broad boxed warnings from menopause-related hormone replacement therapy products based on a recent...[ Price : $8.95]
Roche says its investigational Brutons tyrosine kinase inhibitor fenebrutinib showed the strongest late-stage results yet reported...[ Price : $8.95]
FDA cites Alvotechs Reykjavik, Iceland, manufacturing site for widespread sterility assurance, environmental monitoring, and quali...[ Price : $8.95]
Merck reports positive Phase 3 results for its oral PCSK9 inhibitor enlicitide, showing LDL-cholesterol reductions approaching 60%...[ Price : $8.95]
Fresenius Kabi recalls three lots of its famotidine injection after reserve samples from one lot tested out of specification for e...[ Price : $8.95]
A group of leaders from government, academia, and the pharmaceutical industry call for sweeping federal action to stabilize the U....[ Price : $8.95]
Cogent Biosciences reports positive data from a Phase 3 study of its KIT inhibitor bezuclastinib, saying that the drug combined wi...[ Price : $8.95]
FDA cites Medispray Laboratories, a finished drug product manufacturer based in Ponda, Goa, India, for significant lapses in its q...